| Phong Thanh Phan, MD | |
|
200 Fleetwood Dr, Easley, SC 29640-2022 | |
| (864) 442-7200 | |
| Not Available |
| Full Name | Phong Thanh Phan |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 21 Years |
| Location | 200 Fleetwood Dr, Easley, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275566846 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Oconee Memorial Hospital | Seneca, SC | Hospital |
| Prisma Health Baptist Easley Hospital | Easley, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
A model based on quantitative diffusion tensor imaging findings predicts outcomes after severe traumatic brain injury better than current methods, shows a multicenter study.
Galmed Pharmaceuticals Ltd. ("Galmed") today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.
Chem Rx Corporation, the third largest long-term care pharmacy in the United States, today announced that it has reached a "stalking horse" asset purchase agreement to sell substantially all of the assets of the company to PharMerica Corporation, an industry-leading pharmaceutical services company serving residents in long-term facilities and settings.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.
› Verified 9 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
A model based on quantitative diffusion tensor imaging findings predicts outcomes after severe traumatic brain injury better than current methods, shows a multicenter study.
Galmed Pharmaceuticals Ltd. ("Galmed") today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.
Chem Rx Corporation, the third largest long-term care pharmacy in the United States, today announced that it has reached a "stalking horse" asset purchase agreement to sell substantially all of the assets of the company to PharMerica Corporation, an industry-leading pharmaceutical services company serving residents in long-term facilities and settings.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.
› Verified 9 days ago
| Entity Name | Apogee Medical Group South Carolina |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619028545 PECOS PAC ID: 8921193020 Enrollment ID: O20071004000474 |
News Archive
A model based on quantitative diffusion tensor imaging findings predicts outcomes after severe traumatic brain injury better than current methods, shows a multicenter study.
Galmed Pharmaceuticals Ltd. ("Galmed") today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.
Chem Rx Corporation, the third largest long-term care pharmacy in the United States, today announced that it has reached a "stalking horse" asset purchase agreement to sell substantially all of the assets of the company to PharMerica Corporation, an industry-leading pharmaceutical services company serving residents in long-term facilities and settings.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.
› Verified 9 days ago
| Entity Name | Baptist Easley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144452889 PECOS PAC ID: 0840337606 Enrollment ID: O20091027000684 |
News Archive
A model based on quantitative diffusion tensor imaging findings predicts outcomes after severe traumatic brain injury better than current methods, shows a multicenter study.
Galmed Pharmaceuticals Ltd. ("Galmed") today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.
Chem Rx Corporation, the third largest long-term care pharmacy in the United States, today announced that it has reached a "stalking horse" asset purchase agreement to sell substantially all of the assets of the company to PharMerica Corporation, an industry-leading pharmaceutical services company serving residents in long-term facilities and settings.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.
› Verified 9 days ago
| Entity Name | Southeastern Hospitalist Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003280108 PECOS PAC ID: 3476855420 Enrollment ID: O20160125000378 |
News Archive
A model based on quantitative diffusion tensor imaging findings predicts outcomes after severe traumatic brain injury better than current methods, shows a multicenter study.
Galmed Pharmaceuticals Ltd. ("Galmed") today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.
Chem Rx Corporation, the third largest long-term care pharmacy in the United States, today announced that it has reached a "stalking horse" asset purchase agreement to sell substantially all of the assets of the company to PharMerica Corporation, an industry-leading pharmaceutical services company serving residents in long-term facilities and settings.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phong Thanh Phan, MD 1 Independence Pt Ste 212, Greenville, SC 29615-4536 Ph: (864) 797-6328 | Phong Thanh Phan, MD 200 Fleetwood Dr, Easley, SC 29640-2022 Ph: (864) 442-7200 |
News Archive
A model based on quantitative diffusion tensor imaging findings predicts outcomes after severe traumatic brain injury better than current methods, shows a multicenter study.
Galmed Pharmaceuticals Ltd. ("Galmed") today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.
Chem Rx Corporation, the third largest long-term care pharmacy in the United States, today announced that it has reached a "stalking horse" asset purchase agreement to sell substantially all of the assets of the company to PharMerica Corporation, an industry-leading pharmaceutical services company serving residents in long-term facilities and settings.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Erect radiographs are necessary to rule out unstable cervical spine injuries, UK researchers report.
› Verified 9 days ago
Dr. Mudunuri V Raju, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Fleetwood Dr, Easley, SC 29640 Phone: 864-442-7200 | |
Dr. Ryan Douglas Coultas, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 200 Fleetwood Dr, Easley, SC 29640 Phone: 864-442-7200 Fax: 864-442-8279 | |
Yaneve Shemesh, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 200 Fleetwood Dr, Easley, SC 29640 Phone: 864-442-7200 Fax: 864-442-8279 | |
Emmanuel Andes Fajardo, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 704 N A St, Easley, SC 29640 Phone: 864-859-4480 Fax: 864-859-3750 | |
Dr. Steven Craig Winters Jr., MD Hospitalist Medicare: Medicare Enrolled Practice Location: 200 Fleetwood Dr, Easley, SC 29640 Phone: 864-442-7200 Fax: 864-442-8279 |